CVS Health Co. (NYSE:CVS) Shares Sold by Cullen Investment Group LTD.

Cullen Investment Group LTD. lessened its position in shares of CVS Health Co. (NYSE:CVS) by 35.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,555 shares of the pharmacy operator’s stock after selling 10,619 shares during the quarter. Cullen Investment Group LTD.’s holdings in CVS Health were worth $878,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. American Century Companies Inc. boosted its holdings in shares of CVS Health by 3.0% during the 2nd quarter. American Century Companies Inc. now owns 968,121 shares of the pharmacy operator’s stock worth $57,177,000 after purchasing an additional 28,250 shares during the last quarter. Thoroughbred Financial Services LLC increased its holdings in shares of CVS Health by 31.8% during the 2nd quarter. Thoroughbred Financial Services LLC now owns 4,007 shares of the pharmacy operator’s stock worth $236,000 after buying an additional 967 shares during the last quarter. Fairfield Financial Advisors LTD acquired a new position in CVS Health in the second quarter valued at approximately $40,000. Oldfield Partners LLP increased its stake in CVS Health by 37.8% during the second quarter. Oldfield Partners LLP now owns 6,200 shares of the pharmacy operator’s stock worth $366,000 after acquiring an additional 1,700 shares during the last quarter. Finally, Waycross Partners LLC increased its position in shares of CVS Health by 11.3% during the 2nd quarter. Waycross Partners LLC now owns 207,539 shares of the pharmacy operator’s stock worth $12,257,000 after purchasing an additional 21,135 shares during the last quarter. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. UBS Group upped their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Cantor Fitzgerald reissued a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Evercore ISI raised their price target on CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Finally, Mizuho decreased their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Trading Up 7.4 %

CVS Health stock opened at $51.54 on Tuesday. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $80.75. The stock has a 50-day moving average price of $51.76 and a 200 day moving average price of $56.49. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock has a market cap of $64.86 billion, a PE ratio of 13.08, a P/E/G ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same period last year, the company posted $2.21 earnings per share. The firm’s revenue was up 6.3% compared to the same quarter last year. Equities research analysts predict that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 5.16%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.